IOVANCE BIOTHERAPEUTICS INC COM USD0.000041666 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0JDK for the last quarter is 58.55 M USD, and it's 88.24% higher compared to the previous quarter. The net income of Q3 24 is -83.54 M USD.